Clinically Significant Dysregulation of <i>hsa-miR-30d-5p</i> and <i>hsa-let-7b</i> Expression in Patients with Surgically Resected Non-Small Cell Lung Cancer.

Abstract

Together, these results suggest a possible tumor suppressor role for <i>hsa-miR-30d</i> in lung tumor progression and initiation. Moreover, upregulation of <i>hsa-let-7b</i> was associated with the tumor type.